Health Information, Appointments, and Earnings Release Schedules - Research Report on Medtronic, Stryker, Hologic, ResMed, and Align Technology

Fri Jul 5, 2013 8:02am EDT

* Reuters is not responsible for the content in this press release.

Health Information, Appointments, and Earnings Release Schedules - Research Report on Medtronic, Stryker, Hologic, ResMed, and Align Technology

PR Newswire

NEW YORK, July 5, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

Today, Wall Street Reports announced new research reports highlighting Medtronic, Inc. (NYSE: MDT), Stryker Corp. (NYSE: SYK), Hologic Inc. (NASDAQ: HOLX), ResMed Inc. (NYSE: RMD) and Align Technology Inc. (NASDAQ: ALGN). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Medtronic, Inc. Research Report

On June 26, 2013, Medtronic, Inc. (Medtronic) initiated four medical device notifications to worldwide clinicians about the SynchroMed Implantable Infusion System. According to the Company, these provide clinicians with information to help identify and manage issues that impact the safe and reliable delivery of therapy using the SynchroMed Implantable Infusion System. Medtronic stated that its intrathecal drug delivery systems are used to treat chronic, intractable pain and severe spasticity of cerebral or spinal origin and the Company remains confident in its ability to deliver safe and effective therapy. The US Food and Drug Administration (FDA) has classified three of these notifications as Class I recalls. The fourth notification is an update to a 2011 action related to pump refill which was previously classified by the FDA as a Class I recall. The Full Research Report on Medtronic, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.wsreports.com/r/full_research_report/b199_MDT]

Stryker Corp. Research Report

On June 25, 2013, Stryker Corp's (Stryker) Orthopaedics Division announced the appointment of Hal Sutton as the Company's new spokesperson, who will be involved in educating consumers about hip replacement surgery. Sutton is a professional golfer and was a PGA Tour Champion in 1983, who underwent a total hip replacement and received Stryker's Mobile Bearing Hip in October 2012. As Stryker's spokesperson, Sutton's role will be to help educate current and prospective hip replacement patients around the country, discussing his experiences with osteoarthritis, hip replacement, and the recovery process. Stryker stated that its Mobile Bearing Hip System is designed to provide patients with stability, range of motion and longevity. The Full Research Report on Stryker Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.wsreports.com/r/full_research_report/5339_SYK]

Hologic Inc. Research Report  

On June 26, 2013, Hologic, Inc. (Hologic) announced that the Company plans to release its Q3 FY 2013 operating results on August 5, 2013, Monday, after market hours. Following the release, the Company will host a conference call on the same day at 5:00 p.m. (Eastern Time). The Company will provide a live webcast of the call and interested participants may access it through the Company's website. A replay of the same will also be available an hour after the call ends through August 23, 2013, Friday. The Full Research Report on Hologic Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.wsreports.com/r/full_research_report/d13e_HOLX]

ResMed Inc. Research Report

On June 27, 2013, ResMed Inc. (ResMed) announced the schedule of its conference call and webcast to discuss its Q4 FY 2013 and full-year FY 2013 financial results. The Company will release the results on August 1, 2013, Thursday, and the press release of the same will be issued after 1:00 p.m. PT. In addition, the Company will host a conference call and webcast to review its results, market trends, and future outlook. The conference call is scheduled to begin at 1:30 p.m. US PT and will be webcast on ResMed's website. The Full Research Report on ResMed Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.wsreports.com/r/full_research_report/ba41_RMD]

Align Technology Inc. Research Report

On July 1, 2013, Align Technology, Inc. (Align Technology) announced that the Company will report its Q2 2013 financial results on July 18, 2013, Thursday at 4:00 p.m. ET. The same can be accessed on the Investor Relations section of the Company's website. Following the press release, the Company will host a conference call at 4:30 p.m. ET, to discuss its financial results. The call will also be available as an audio web cast live via the Internet at the Company's website. The Full Research Report on Align Technology Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.wsreports.com/r/full_research_report/67be_ALGN]

EDITOR NOTES:

  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  5. For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

SOURCE Wall Street Reports

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.